Compare ELOX & STKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ELOX | STKE |
|---|---|---|
| Founded | N/A | 2002 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.0M | 38.3M |
| IPO Year | 2013 | 2021 |
| Metric | ELOX | STKE |
|---|---|---|
| Price | $20.62 | $1.38 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 43.1K | ★ 134.9K |
| Earning Date | N/A | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $552.94 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.00 | $0.85 |
| 52 Week High | $19.96 | $7.75 |
| Indicator | ELOX | STKE |
|---|---|---|
| Relative Strength Index (RSI) | 63.00 | 62.85 |
| Support Level | $16.50 | $1.18 |
| Resistance Level | $19.66 | $1.42 |
| Average True Range (ATR) | 1.73 | 0.07 |
| MACD | -0.05 | 0.03 |
| Stochastic Oscillator | 61.99 | 93.53 |
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.
Sol Strategies Inc is engaged in investing in blockchain technologies and crypto currencies. Company executes its Investment Objective through three lines of effort: Treasury management: Maintaining a core portfolio of cryptocurrencies for long-term growth, enhanced with risk management strategies to minimize volatility, and generating yield through lending, staking, and liquidity provisioning; Private equity focused on early stage companies in the DeFi and blockchain sectors; and Active investments to generate yield through strategic activities, including Bitcoin mining and stalking and validating Solana.